Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2008

Jul 23, 2008

29777_dirs_2008-07-23_85165c4c-4acb-4e65-ab5d-bd3082da2430.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-07-21

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-07-21 Common shares without par value M 27848 $53.19 Acquired 344989 Direct
2008-07-21 Common shares without par value F 26563 $57.58 Disposed 318426 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-07-21 Common shares without par value $53.19 M 27848 Disposed 2009-02-11 Common shares (27848) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 20492 Indirect
Common shares without par value 1197 Indirect
Common shares without par value 1197 Indirect
Common shares without par value 1197 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of July 18, 2008

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons.